SC
EGRX

Savant Capital’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Savant Capital’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-16,654
Closed -$87.3K – 1349
2024
Q1 		$87.3K Buy
+16,654
New +$87.3K ﹤0.01% 1077